Six months ago, 4-year-old Jose Morales-Ortiz was struggling to say two-word sentences. Jose has severe autism, and he couldn’t have a conversation and wouldn’t answer to his name most of the time — ...
Name brand GLP-1 drugs like Ozempic and Wegovy have quickly become household names, akin to Tylenol or Advil, and their rise in popularity is only increasing. Originally developed to treat Type 2 ...
Shortages and big price tags have driven patients to unconventional sources of GLP-1 drugs In late 2022, pharmacist Joseph Lambson got an unusual call from a poison control specialist. He said, “Hey ...
In December 2017, the FDA approved a new injectable drug to treat type 2 diabetes called semaglutide, which you likely know by its brand name: Ozempic. A few years later, during the pandemic, Wegovy, ...
A new human liver organoid microarray developed by Cincinnati Children’s and Roche recreates immune-driven liver injury in the lab. Built from patient-derived stem cells and immune cells, it ...
The obesity drug liraglutide cut migraine days in half in a small trial, though more research is needed to exclude the placebo effect, researchers said. When you purchase through links on our site, we ...
In 1954, researchers described a new drug that sent children with acute leukemia into remission. It would become one of the first chemotherapy drugs and would later form the basis for a new, "rational ...
GLP-1 medications like Ozempic have dominated headlines over the past couple of years. When writing his new book, Diet, Drugs and Dopamine: The New Science of Achieving a Healthy Weight, former FDA ...
Ozempic, Mounjaro, and Zepbound can drive impressive weight loss, but stopping them is often followed by rapid weight regain.
Alexis Quinter, a forensic chemist at the Center for Forensic Science Research and Education in Horsham, Pennsylvania, performs an extraction process on a batch of drug samples from Trenton, New ...
Kendra Pierre-Louis: For Scientific American’s Science Quickly, I’m Kendra Pierre-Louis, in for Rachel Feltman. Over the past few years GLP-1 drugs have gone from relatively obscure diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results